1500TiP REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design
Annals of Oncology（2023）
关键词
pembrolizumab,cell refine-lung cancer,refine-lung cancer,multicentre phase iii study,non-small,multi-arm
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要